ONKURE THERAPEUTICS INC-A (OKUR) Stock Earnings & Estimates
USA - NASDAQ:OKUR - US68277Q1058 - Common Stock
2.51 USD
-0.03 (-1.18%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 50.00% | |||||||
| EBITDA YoY % growth | -15.44M | -19.51M -26.36% | -39.77M -103.84% | -53.76M -35.18% | -82.883M -54.17% | -53.724M 35.18% | N/A 45.15% | N/A | N/A | |
| EBIT YoY % growth | -15.47M | -19.55M -26.37% | -39.82M -103.68% | -53.85M -35.23% | -83.053M -54.23% | -54.386M 34.52% | N/A -26.42% | N/A -6.41% | N/A -3.59% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -4.86 | -2.12 56.38% | -2.53 -19.34% | -6.57 -159.68% | N/A 29.02% | N/A 23.50% | N/A 9.84% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.22 -11.09% | -1.11 18.70% | -1.03 13.43% | -1.05 7.84% | -1.07 12.35% | -1.09 2.01% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.133M -267.34% | -17.638M 47.81% | -18.075M -6.33% | -18.577M -13.80% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.14 28.75% | -1.27 | 0.13 | 10.44% |
| Q1 2025 Q2Q % growth | -1.19 52.40% | -1.49 | 0.30 | 20.09% |
| Q4 2024 Q2Q % growth | -1.37 -92.96% | -0.75 | -0.62 | -81.51% |
| Q3 2024 Q2Q % growth | -1.10 -92.98% | -1.05 | -0.05 | -4.70% |
| Q2 2024 Q2Q % growth | -1.60 -146.15% | -1.02 | -0.58 | -56.86% |
| Q1 2024 Q2Q % growth | -2.50 -316.67% | -4.45 | 1.95 | 43.87% |
| Q4 2023 Q2Q % growth | -0.71 -26.79% | -0.59 | -0.12 | -20.47% |
| Q3 2023 Q2Q % growth | -0.57 -7.55% | -0.58 | 0.01 | 2.21% |
| Q2 2023 Q2Q % growth | -0.65 -30.00% | -0.53 | -0.12 | -23.34% |
| Q1 2023 Q2Q % growth | -0.60 -13.21% | -0.62 | 0.02 | 2.61% |
| Q4 2022 Q2Q % growth | -0.56 -30.23% | -0.61 | 0.05 | 8.62% |
| Q3 2022 Q2Q % growth | -0.53 -1.92% | -0.58 | 0.05 | 9.11% |
| Q2 2022 Q2Q % growth | -0.50 -16.28% | -0.59 | 0.09 | 15.77% |
| Q1 2022 Q2Q % growth | -0.53 84.77% | -0.55 | 0.02 | 4.37% |
| Q4 2021 Q2Q % growth | -0.43 | -0.58 | 0.15 | 26.04% |
| Q3 2021 Q2Q % growth | -0.52 | -0.48 | -0.04 | -7.71% |
| Q2 2021 Q2Q % growth | -0.43 | -0.38 | -0.05 | -11.92% |
| Q1 2021 Q2Q % growth | -3.48 | -0.39 | -3.09 | -797.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.85% | 0.07% | 5.73% |
| Revenue | N/A | N/A | N/A | -100% |